During the past decade, Keystone Research Ltd. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
2019-08-13
2020-04-07
Completed
132
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Keystone Research Ltd." #1 sponsor was "Aerie Pharmaceuticals" with 2 trials, followed by "Allergan" with 2 trials
sponsored, "Formosa Pharmaceuticals, Inc." with 2 trials sponsored, "Actavis Inc." with 1 trials sponsored and "Alcon Research"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Keystone Research Ltd."
#1 collaborator was "CBCC Global Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Keystone Research Ltd.
According to Clinical.Site data, the most researched conditions in "Keystone Research Ltd." are
"Ocular Hypertension" (5 trials), "Glaucoma, Open-Angle" (4 trials), "Glaucoma" (2 trials), "Ocular Inflammation and Pain" (2 trials) and "Open-Angle Glaucoma" (2 trials). Many other conditions were trialed in "Keystone Research Ltd." in a lesser frequency.
Clinical Trials Intervention Types at Keystone Research Ltd.
Most popular intervention types in "Keystone Research Ltd." are "Drug" (12 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "APP13007, 0.05%" (2 trials), "0.005% latanoprost" (1 trials), "APP13007 Placebo, 0.05%" (1 trials) and "APP13007 Placebo, 0.1%" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Keystone Research Ltd.
The vast majority of trials in "Keystone Research Ltd." are
14 trials for "All" genders.
Clinical Trials Status at Keystone Research Ltd.
Currently, there are NaN active trials in "Keystone Research Ltd.".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Keystone Research Ltd.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Keystone Research Ltd., 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".